⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11890395 | 1.00 | — | — | |
| SCHEMBL12736716 | 1.00 | — | — | |
| SCHEMBL24375382 | 0.78 | — | — | |
| SCHEMBL5157165 | 0.75 | — | — | |
| SCHEMBL809056 | 0.75 | — | — | |
| SCHEMBL16786164 | 0.75 | — | — | |
| SCHEMBL10931279 | 0.75 | — | — | |
| SCHEMBL809057 | 0.75 | — | — | |
| SCHEMBL7970728 | 0.75 | — | — | |
| SCHEMBL15147670 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1951838-A2 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007053697-A2 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-10 | — | — | WO | disclosed |
| US-6506775-B1 | Treatment of a gastrointestinal disorder; a central nervous system (CNS) adverse conditions caused by Heliobacter pylori; or angiogenesis especially CNS disorders in a mammalian subject, especially humans. | PFIZER INC | 2003-01-14 | — | — | US | disclosed |
| US-6329396-B1 | TREATMENT OF GASTROINTESTINAL DISORDERS CENTRAL NERVOUS SYSTEM (CNS) DISORDERS; INFLAMMATORY DISEASE; EMESIS; URINARY INCONTINENCE; PAIN; MIGRAINE; SUNBURN; DISEASES, DISORDERS AND ADVERSE CONDITIONS CAUSED BY HELIOBACTER PYLORI; OR | PFIZER INC. | 2001-12-11 | — | — | US | disclosed |
| EP-0861235-B1 | SUBSTITUTED BENZYLAMINOPIPERIDINE COMPOUNDS | PFIZER (US) | 2001-11-07 | — | — | EP | disclosed |
| EP-1114817-A1 | Substituted benzylamino piperidine compounds | PFIZER INC. (US) | 2001-07-11 | — | — | EP | disclosed |